| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06 |
| filingDate |
1989-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65e81c32e53105bab980b1e76c6ffc89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8cf7f774b5421754c959dfe1b1ca1b1 |
| publicationDate |
1990-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0365213-A2 |
| titleOfInvention |
Method of resolving cis 3-amino-4-[2-(2-furyl)vinyl]-1-methoxy-carbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof |
| abstract |
Cis αα,ββ-3-amino-4-[2-(2-furyl)vinyl-1-yl]-1-methoxycarbonylmethyl-azetidin-2-one is resolved via optically active di-p-toluoyl tartaric acid. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6462229-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2664600-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9201694-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0017153-A1 |
| priorityDate |
1988-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |